You may sometimes have felt like you "have come down with a virus," meaning that you became sick from being exposed to something that could have been a virus. In fact, you have a virus—actually, many—all the time. Some ...
Feb 21, 2020
0
1
In just six months, the world's largest randomized control trial on COVID-19 therapeutics has generated conclusive evidence on the effectiveness of repurposed drugs for the treatment of COVID-19.
Oct 16, 2020
0
3
A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma.
Mar 8, 2012
0
0
Herpes viruses are like tiny powder kegs waiting to explode. For more than 20 years scientists suspected that herpes viruses were packaged so full of genetic material that they built up an internal pressure so strong it could ...
Jul 24, 2013
1
0
Humans possess a formidable multi-layered defense system that protects us against viral infections. Better understanding of these defenses and the tricks that viruses use to evade them could open novel avenues for treating ...
Feb 11, 2021
0
14
New research findings point toward a class of compounds that could be effective in combating infections caused by enterovirus D68, which has stricken children with serious respiratory infections and might be associated with ...
Jan 1, 2015
1
0
COVID-19 is anticipated to keep causing regular outbreak waves for the foreseeable future. The recent COVID-19 waves have caused fewer hospitalizations and deaths than the initial ones, which is largely due to the immunity ...
Aug 8, 2022
0
38
Scientists at The Scripps Research Institute have determined the atomic structure of a protein that the Lassa fever virus uses to make copies of itself within infected cells. The structural data reveal an unexpected molecular ...
Nov 15, 2011
0
0
(HealthDay)—A drug used against a common virus may lengthen the lives of people with a deadly form of brain cancer, a preliminary study suggests.
Sep 5, 2013
0
0
(HealthDay)—Gilead Sciences has applied to the U.S. Food and Drug Administration for approval for its COVID-19 treatment, remdesivir. The antiviral drug will take the brand name Veklury, the company said.
Aug 12, 2020
0
1
